Position in RDNT
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$22,848,056
+$1,511,267 QoQ
Shares Held
370,489
-3.0% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $122,557,718 across 3 Diagnostics & Research names. RDNT ranks #3 (18.6% of the industry book) .
All Filings in RDNT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,848,056 | 370,489 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $21,336,789 | 381,764 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $28,162,915 | 394,715 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $48,939,547 | 642,167 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $38,263,779 | 672,356 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $32,080,437 | 645,222 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $45,898,079 | 657,189 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $46,439,257 | 669,250 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $38,176,153 | 647,932 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $32,649,838 | 670,979 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $19,075,899 | 548,631 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $12,503,336 | 443,538 | Shares | Sole | 2023-10-26 | |
| No filing history on record for this holder in this stock. | ||||||